These results suggest that UBQLN2 dysregulation in neurons can drive NF-κB activation and cytosolic TDP-43 aggregation, supporting the concept of pathway convergence in ALS pathogenesis. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.